Barinthus Biotherapeutics plc.
BRNSDelisted Sep 9, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001828185
Barinthus Biotherapeutics plc. was delisted on Sep 9, 2026; its insiders filed their last Form 4 on Sep 11, 2026; 15 institutions reported holding it in 13F filings for Q2 2026, worth $7.84M in total; no superinvestor held it.
13F holders, Q2 2026
Institutional positions in Barinthus Biotherapeutics plc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 15
- +1 vs. Q1 2026
- Shares held
- 9.20M
- −93.8K (−1.0%) vs. Q1 2026
- Total value
- $7.84M
- −$46.1K (−0.6%) vs. Q1 2026
- New holders
- 3
- 2 more added
- Sold out
- 2
- 2 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BRNS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 15 | $7.84M |
| Q1 2026 | 14 | $7.89M |
| Q4 2025 | 13 | $6.10M |
| Q3 2025 | 15 | $10.4M |
| Q2 2025 | 14 | $9.02M |
| Q1 2025 | 15 | $9.15M |
| Q4 2024 | 16 | $10.3M |
| Q3 2024 | 19 | $10.7M |
| Q2 2024 | 18 | $11.8M |
| Q1 2024 | 15 | $21.3M |
| Q4 2023 | 15 | $36.5M |
| Q3 2023 | 16 | $29.5M |
| Q2 2023 | 15 | $20.0M |
| Q1 2023 | 13 | $21.6M |
| Q4 2022 | 15 | $22.2M |
| Q3 2022 | 11 | $31.2M |
| Q2 2022 | 13 | $27.5M |
| Q1 2022 | 12 | $23.8M |
| Q4 2021 | 15 | $54.3M |
| Q3 2021 | 15 | $77.6M |
| Q2 2021 | 19 | $76.8M |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Barinthus Biotherapeutics plc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| M&G Plc | 5,197,349 | $5.20M | 0.03% | 00.0% | Unchanged |
| SC China Holding Ltd | 1,420,473 | $937.5K | 0.08% | 00.0% | Unchanged |
| GLR Partners, LLC | 1,243,377 | $820.6K | 0.38% | 00.0% | Unchanged |
| DC Funds, LP | 642,204 | $423.9K | 33.82% | 00.0% | Unchanged |
| Rangeley Capital, LLC | 185,136 | $122.2K | 0.12% | +25,671+16.1% | Added |
| Johns Hopkins University | 122,237 | $80.7K | 0.01% | 00.0% | Unchanged |
| Morgan Stanley | 108,843 | $71.8K | 0.00% | +106,633+4,825.0% | Added |
| Baird Financial Group, Inc. | 105,961 | $69.9K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 76,754 | $50.7K | 0.00% | −42,242−35.5% | Reduced |
| HighTower Advisors, LLC | 37,450 | $24.7K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 25,000 | $16.5K | 0.00% | −126,000−83.4% | Reduced |
| XTX Topco Ltd | 14,819 | $9.78K | 0.00% | +14,819 | New |
| Rhumbline Advisers | 11,685 | $7.71K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 11,052 | $7.29K | 0.00% | +11,052 | New |
| UBS Group AG | 1,008 | $665 | 0.00% | +1,008 | New |
| GTS Securities LLC | 0 | $0 | 0.00% | −73,210−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −11,568−100.0% | Sold out |